FKBP5 and endometrium adenocarcinoma: Our previous research indicated that reduced FKBP5 levels in endometrial adenocarcinoma tissues promote cancer cell proliferation by increasing p-AKT levels while simultaneously decreasing the sensitivity of these cancer cells to progesterone therapy.